Graefen, M.

patient prostate cancer center disease prostate cancer sc disease assay range urology antigen biopsy <0.001 diverent value surgery table study prostate-speciwc antigen number volume nomogram university survival signiwcantly prostatectomy model prostate volume result prostate-speciwc 4–10 european 2–4 population 4–10 ng /ml department treatment stage 2–10 prostate-speci fic antigen lein m comparison lymph node dissection outcome gleason speciwcity performance hospital center 2 pca patients accuracy factor adjuvant briganti lymph tumor stage biopsy gleason sum csm-free survival rates 1366 patients stephan multivariable preoperative tumor analyses detection wve centers therapy prostate speciwc antigen diverent psa assays joniau network speciwc tpsa range immulite characteristic screening jung k loening auc values center 3